Milbank Advises in Connection with Grifols’ €300M Private Placement of Senior Secured Notes

Milbank LLP advised the placement agents and note purchasers in connection with Grifols’ privately placed tap issuance of €300 million principal amount of its senior secured notes due 2030.

The proceeds from the offering are expected to be used to repay certain amounts outstanding under Grifols’ revolving loans.

As a leading global producer of plasma medicines, Grifols has a presence in more than 110 countries and is the world leader in plasma collection, with more than 390 plasma donation centers across North America, Europe, Africa, the Middle East and China. The company is headquartered in Barcelona, Spain and employs more than 23,000 people worldwide.

The Milbank teams were led by Corporate Finance and Securities partners Apostolos Gkoutzinis and Trevor Truman, Leveraged Finance partner Meir S. Hornung, and associates Stefanos Serfas and Alexandros Makris.